PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgical intensive care unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.\', \'Department of Pharmacy, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.\', \'Department of Intensive care unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.\', \'The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.\', \'Department of Anesthesiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.\', \'Department of Intensive care unit, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Electronic address: cwicu@bjsjth.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(21)00878-X10.1016/j.intimp.2021.108242
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34688136
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all